Core Insights - The company reported a total revenue of 9.116 billion yuan and a net profit attributable to shareholders of 1.754 billion yuan for Q3 2025 [1] - The operating cash flow net inflow was 2.525 billion yuan [1] Financial Metrics - The latest debt-to-asset ratio stands at 37.37% [3] - The gross profit margin is reported at 66.39% [3] - The return on equity (ROE) is 12.56% [3] - The diluted earnings per share (EPS) is 1.96 yuan [3] - The total asset turnover ratio is 0.37 times [3] - The inventory turnover ratio is 1.68 times [3] Shareholder Information - The number of shareholders is 47,400, with the top ten shareholders holding a total of 5.98 billion shares, accounting for 66.15% of the total share capital [3] - The largest shareholder is Hong Kong Central Clearing (Agent) Co., Ltd., holding 33.0% [3] - Health元药业集团股份有限公司 is the second-largest shareholder with 24.4% [3]
丽珠集团(000513.SZ):2025年三季报净利润为17.54亿元